cited_by cdi_FETCH-LOGICAL-c395t-4a94a86032d5f79ea78e1659b2fda0689538263ad0069a9e6dd61a8dd85727ae3
cites cdi_FETCH-LOGICAL-c395t-4a94a86032d5f79ea78e1659b2fda0689538263ad0069a9e6dd61a8dd85727ae3
container_end_page 107
container_issue 1
container_start_page 105
container_title Acta oncologica
container_volume 49
creator Spector, Elena
Franklin, Michael J.
Truskinovsky, Alexander M.
Dudek, Arkadiusz Z.
description
doi_str_mv 10.3109/02841860903147532
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733858223</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733858223</sourcerecordid><originalsourceid>FETCH-LOGICAL-c395t-4a94a86032d5f79ea78e1659b2fda0689538263ad0069a9e6dd61a8dd85727ae3</originalsourceid><addsrcrecordid>eNp9kEtLAzEUhYMotlZ_gBuZnavRPCYvXEnxBQUXKnQ33E4yNGVmUpPMov_elBZcCK7uhfvdwzkHoWuC7xjB-h5TVRElsMaMVJIzeoKmRHBSUiqWp2i6v5cZWE7QRYwbjDFlkp-jCdGSEIrFFC0-fIDWDm5VuMGMjY3FFkJy0BXBxq0fos2HorcJYoLkmryasesg7Iq03gXvTNFAaNzge7hEZy100V4d5wx9PT99zl_LxfvL2_xxUTZM81RWoCvIthk1vJXaglQ229Yr2hrAQmnOFBUMDMZCg7bCGEFAGaO4pBIsm6Hbg-42-O_RxlT3LjY2uxqsH2MtGVNcUcoySQ5kE3yMwbb1Nrg-m68Jrvcd1n86zD83R_VxlcP-fhxLy8DDAXBD60MPawtdWucWbL3xYxhy9H_kfwBBMH8X</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733858223</pqid></control><display><type>article</type><title>Sorafenib induces partial response in metastatic medullary thyroid carcinoma</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Spector, Elena ; Franklin, Michael J. ; Truskinovsky, Alexander M. ; Dudek, Arkadiusz Z.</creator><creatorcontrib>Spector, Elena ; Franklin, Michael J. ; Truskinovsky, Alexander M. ; Dudek, Arkadiusz Z.</creatorcontrib><identifier>ISSN: 0284-186X</identifier><identifier>EISSN: 1651-226X</identifier><identifier>DOI: 10.3109/02841860903147532</identifier><identifier>PMID: 19711206</identifier><language>eng</language><publisher>England: Informa UK Ltd. (Informa Healthcare, Taylor &amp; Francis AS)</publisher><subject>Adult ; Antineoplastic Agents - therapeutic use ; Benzenesulfonates - therapeutic use ; Bone Neoplasms - drug therapy ; Bone Neoplasms - secondary ; Carcinoma, Neuroendocrine - complications ; Carcinoma, Neuroendocrine - drug therapy ; Carcinoma, Neuroendocrine - secondary ; Humans ; Immunohistochemistry ; Lung Neoplasms - drug therapy ; Lung Neoplasms - secondary ; Lymphatic Metastasis - pathology ; Male ; Mediastinal Neoplasms - drug therapy ; Mediastinal Neoplasms - secondary ; Neoplasm Metastasis - drug therapy ; Neoplasm Metastasis - pathology ; Niacinamide - analogs &amp; derivatives ; Phenylurea Compounds ; Positron-Emission Tomography ; Pyridines - therapeutic use ; Schistosomiasis - complications ; Skin Neoplasms - drug therapy ; Skin Neoplasms - secondary ; Soft Tissue Neoplasms - drug therapy ; Soft Tissue Neoplasms - secondary ; Thyroid Neoplasms - complications ; Thyroid Neoplasms - drug therapy ; Thyroid Neoplasms - pathology</subject><ispartof>Acta oncologica, 2010, Vol.49 (1), p.105-107</ispartof><rights>Informa UK Ltd 2010</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c395t-4a94a86032d5f79ea78e1659b2fda0689538263ad0069a9e6dd61a8dd85727ae3</citedby><cites>FETCH-LOGICAL-c395t-4a94a86032d5f79ea78e1659b2fda0689538263ad0069a9e6dd61a8dd85727ae3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19711206$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Spector, Elena</creatorcontrib><creatorcontrib>Franklin, Michael J.</creatorcontrib><creatorcontrib>Truskinovsky, Alexander M.</creatorcontrib><creatorcontrib>Dudek, Arkadiusz Z.</creatorcontrib><title>Sorafenib induces partial response in metastatic medullary thyroid carcinoma</title><title>Acta oncologica</title><addtitle>Acta Oncol</addtitle><subject>Adult</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Benzenesulfonates - therapeutic use</subject><subject>Bone Neoplasms - drug therapy</subject><subject>Bone Neoplasms - secondary</subject><subject>Carcinoma, Neuroendocrine - complications</subject><subject>Carcinoma, Neuroendocrine - drug therapy</subject><subject>Carcinoma, Neuroendocrine - secondary</subject><subject>Humans</subject><subject>Immunohistochemistry</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - secondary</subject><subject>Lymphatic Metastasis - pathology</subject><subject>Male</subject><subject>Mediastinal Neoplasms - drug therapy</subject><subject>Mediastinal Neoplasms - secondary</subject><subject>Neoplasm Metastasis - drug therapy</subject><subject>Neoplasm Metastasis - pathology</subject><subject>Niacinamide - analogs &amp; derivatives</subject><subject>Phenylurea Compounds</subject><subject>Positron-Emission Tomography</subject><subject>Pyridines - therapeutic use</subject><subject>Schistosomiasis - complications</subject><subject>Skin Neoplasms - drug therapy</subject><subject>Skin Neoplasms - secondary</subject><subject>Soft Tissue Neoplasms - drug therapy</subject><subject>Soft Tissue Neoplasms - secondary</subject><subject>Thyroid Neoplasms - complications</subject><subject>Thyroid Neoplasms - drug therapy</subject><subject>Thyroid Neoplasms - pathology</subject><issn>0284-186X</issn><issn>1651-226X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp9kEtLAzEUhYMotlZ_gBuZnavRPCYvXEnxBQUXKnQ33E4yNGVmUpPMov_elBZcCK7uhfvdwzkHoWuC7xjB-h5TVRElsMaMVJIzeoKmRHBSUiqWp2i6v5cZWE7QRYwbjDFlkp-jCdGSEIrFFC0-fIDWDm5VuMGMjY3FFkJy0BXBxq0fos2HorcJYoLkmryasesg7Iq03gXvTNFAaNzge7hEZy100V4d5wx9PT99zl_LxfvL2_xxUTZM81RWoCvIthk1vJXaglQ229Yr2hrAQmnOFBUMDMZCg7bCGEFAGaO4pBIsm6Hbg-42-O_RxlT3LjY2uxqsH2MtGVNcUcoySQ5kE3yMwbb1Nrg-m68Jrvcd1n86zD83R_VxlcP-fhxLy8DDAXBD60MPawtdWucWbL3xYxhy9H_kfwBBMH8X</recordid><startdate>2010</startdate><enddate>2010</enddate><creator>Spector, Elena</creator><creator>Franklin, Michael J.</creator><creator>Truskinovsky, Alexander M.</creator><creator>Dudek, Arkadiusz Z.</creator><general>Informa UK Ltd. (Informa Healthcare, Taylor &amp; Francis AS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2010</creationdate><title>Sorafenib induces partial response in metastatic medullary thyroid carcinoma</title><author>Spector, Elena ; Franklin, Michael J. ; Truskinovsky, Alexander M. ; Dudek, Arkadiusz Z.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c395t-4a94a86032d5f79ea78e1659b2fda0689538263ad0069a9e6dd61a8dd85727ae3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Benzenesulfonates - therapeutic use</topic><topic>Bone Neoplasms - drug therapy</topic><topic>Bone Neoplasms - secondary</topic><topic>Carcinoma, Neuroendocrine - complications</topic><topic>Carcinoma, Neuroendocrine - drug therapy</topic><topic>Carcinoma, Neuroendocrine - secondary</topic><topic>Humans</topic><topic>Immunohistochemistry</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - secondary</topic><topic>Lymphatic Metastasis - pathology</topic><topic>Male</topic><topic>Mediastinal Neoplasms - drug therapy</topic><topic>Mediastinal Neoplasms - secondary</topic><topic>Neoplasm Metastasis - drug therapy</topic><topic>Neoplasm Metastasis - pathology</topic><topic>Niacinamide - analogs &amp; derivatives</topic><topic>Phenylurea Compounds</topic><topic>Positron-Emission Tomography</topic><topic>Pyridines - therapeutic use</topic><topic>Schistosomiasis - complications</topic><topic>Skin Neoplasms - drug therapy</topic><topic>Skin Neoplasms - secondary</topic><topic>Soft Tissue Neoplasms - drug therapy</topic><topic>Soft Tissue Neoplasms - secondary</topic><topic>Thyroid Neoplasms - complications</topic><topic>Thyroid Neoplasms - drug therapy</topic><topic>Thyroid Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Spector, Elena</creatorcontrib><creatorcontrib>Franklin, Michael J.</creatorcontrib><creatorcontrib>Truskinovsky, Alexander M.</creatorcontrib><creatorcontrib>Dudek, Arkadiusz Z.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Acta oncologica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Spector, Elena</au><au>Franklin, Michael J.</au><au>Truskinovsky, Alexander M.</au><au>Dudek, Arkadiusz Z.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sorafenib induces partial response in metastatic medullary thyroid carcinoma</atitle><jtitle>Acta oncologica</jtitle><addtitle>Acta Oncol</addtitle><date>2010</date><risdate>2010</risdate><volume>49</volume><issue>1</issue><spage>105</spage><epage>107</epage><pages>105-107</pages><issn>0284-186X</issn><eissn>1651-226X</eissn><cop>England</cop><pub>Informa UK Ltd. (Informa Healthcare, Taylor &amp; Francis AS)</pub><pmid>19711206</pmid><doi>10.3109/02841860903147532</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0284-186X
ispartof Acta oncologica, 2010, Vol.49 (1), p.105-107
issn 0284-186X
1651-226X
language eng
recordid cdi_proquest_miscellaneous_733858223
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Adult
Antineoplastic Agents - therapeutic use
Benzenesulfonates - therapeutic use
Bone Neoplasms - drug therapy
Bone Neoplasms - secondary
Carcinoma, Neuroendocrine - complications
Carcinoma, Neuroendocrine - drug therapy
Carcinoma, Neuroendocrine - secondary
Humans
Immunohistochemistry
Lung Neoplasms - drug therapy
Lung Neoplasms - secondary
Lymphatic Metastasis - pathology
Male
Mediastinal Neoplasms - drug therapy
Mediastinal Neoplasms - secondary
Neoplasm Metastasis - drug therapy
Neoplasm Metastasis - pathology
Niacinamide - analogs & derivatives
Phenylurea Compounds
Positron-Emission Tomography
Pyridines - therapeutic use
Schistosomiasis - complications
Skin Neoplasms - drug therapy
Skin Neoplasms - secondary
Soft Tissue Neoplasms - drug therapy
Soft Tissue Neoplasms - secondary
Thyroid Neoplasms - complications
Thyroid Neoplasms - drug therapy
Thyroid Neoplasms - pathology
title Sorafenib induces partial response in metastatic medullary thyroid carcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T18%3A47%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sorafenib%20induces%20partial%20response%20in%20metastatic%20medullary%20thyroid%20carcinoma&rft.jtitle=Acta%20oncologica&rft.au=Spector,%20Elena&rft.date=2010&rft.volume=49&rft.issue=1&rft.spage=105&rft.epage=107&rft.pages=105-107&rft.issn=0284-186X&rft.eissn=1651-226X&rft_id=info:doi/10.3109/02841860903147532&rft_dat=%3Cproquest_cross%3E733858223%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c395t-4a94a86032d5f79ea78e1659b2fda0689538263ad0069a9e6dd61a8dd85727ae3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733858223&rft_id=info:pmid/19711206&rfr_iscdi=true